The Multiple Sclerosis Society is calling for the National Institute for Clinical Excellence to look at the provision of beta interferon to ensure it is 'available equitably to those patients whose consultants believe they will benefit from it'. In an adjournment debate in the House of Commons, MP John Bercow ...